-
1
-
-
77955761235
-
-
Institute for Clinical Systems Improvement 6th edn. Bloomington, MN: Institute for Clinical Systems Improvement Available Last accessed 19 May 2009
-
Institute for Clinical Systems Improvement. Health Care Guideline: Assessment and Management of Acute Pain. 6th edn. Bloomington, MN: Institute for Clinical Systems Improvement, 2008. Available at: http://www.icsi.org/pain- acute/ pain-acute-assessment-and-management-of-3.html [Last accessed 19 May 2009]
-
(2008)
Health Care Guideline: Assessment and Management of Acute Pain
-
-
-
2
-
-
58949087497
-
American pain society-american academy of pain medicine opioids guidelines panel. clinical guidelines for the use of chronic opioid therapy
-
Chou R, Fanciullo GJ, Fine PG, et al. American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy. J Pain 2009;10:113-30
-
(2009)
J Pain
, vol.10
, pp. 113-30
-
-
Chou, R.1
Fanciullo, G.J.2
Fine, P.G.3
-
4
-
-
23744492940
-
American Pain Society recommendations for improving the quality of acute and cancer pain management: American Pain Society quality of care task force
-
DOI 10.1001/archinte.165.14.1574
-
Gordon DB, Dahl JL, Miaskowski C, et al. American Pain Society recommendations for improving the quality of acute and cancer pain management: American Pain Society Quality of Care Task Force. Arch Intern Med 2005; 165:1574-80 (Pubitemid 41124150)
-
(2005)
Archives of Internal Medicine
, vol.165
, Issue.14
, pp. 1574-1580
-
-
Gordon, D.B.1
Dahl, J.L.2
Miaskowski, C.3
McCarberg, B.4
Todd, K.H.5
Paice, J.A.6
Lipman, A.G.7
Bookbinder, M.8
Sanders, S.H.9
Turk, D.C.10
Carr, D.B.11
-
5
-
-
37149032448
-
Transition from acute to chronic pain and disability: A model including cognitive, affective, and trauma factors
-
DOI 10.1016/j.pain.2007.03.032, PII S0304395907001649
-
Casey CY, Greenberg MA, Nicassio PM, et al. Transition from acute to chronic pain and disability: a model including cognitive, affective, and trauma factors. Pain 2008;134:69-79 (Pubitemid 350258593)
-
(2008)
Pain
, vol.134
, Issue.1-2
, pp. 69-79
-
-
Young Casey, C.1
Greenberg, M.A.2
Nicassio, P.M.3
Harpin, R.E.4
Hubbard, D.5
-
6
-
-
33646344701
-
Persistent postsurgical pain: Risk factors and prevention
-
DOI 10.1016/S0140-6736(06)68700-X, PII S014067360668700X
-
Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet 2006;367:1618-25 (Pubitemid 43674227)
-
(2006)
Lancet
, vol.367
, Issue.9522
, pp. 1618-1625
-
-
Kehlet, H.1
Jensen, T.S.2
Woolf, C.J.3
-
7
-
-
66349134470
-
Transition from acute to chronic postsurgical pain: Risk factors and protective factors
-
Katz J, Seltzer Z. Transition from acute to chronic postsurgical pain: risk factors and protective factors. Expert Rev Neurother 2009;9:723-44
-
(2009)
Expert Rev Neurother
, vol.9
, pp. 723-44
-
-
Katz, J.1
Seltzer, Z.2
-
8
-
-
33749017657
-
Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain
-
DOI 10.1185/030079906X132398
-
Bhamb B, Brown D, Hariharan J, et al. Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin 2006;22:1859-65 (Pubitemid 44449242)
-
(2006)
Current Medical Research and Opinion
, vol.22
, Issue.9
, pp. 1859-1865
-
-
Bhamb, B.1
Brown, D.2
Hariharan, J.3
Anderson, J.4
Balousek, S.5
Fleming, M.F.6
-
9
-
-
77957904093
-
-
Substance Abuse and Mental Health Services Administration (Office of Applied Studies, NSDUH Series H-38A, HHS Publication No. SMA10-4586 Findings). Rockville, MD Available Last accessed 23 December 2010
-
Substance Abuse and Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings (Office of Applied Studies, NSDUH Series H-38A, HHS Publication No. SMA10-4586 Findings). Rockville, MD, 2010. Available at: http://oas.samhsa. gov/NSDUH/2k9NSDUH/2k9ResultsP.pdf [Last accessed 23 December 2010]
-
(2010)
Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings
-
-
-
10
-
-
0003844776
-
-
Institute of Medicine Niacin Washington, DC: National Academy of Sciences/The National Academies Press
-
Institute of Medicine. Niacin. In: Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy of Sciences/The National Academies Press, 1998:123-49
-
(1998)
Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline
, pp. 123-49
-
-
-
11
-
-
79951660718
-
-
Minneapolis MN Upsher-Smith Laboratories, Inc.
-
Niacor [package insert]. Minneapolis, MN: Upsher-Smith Laboratories, Inc., 2007
-
(2007)
Niacor [Package Insert]
-
-
-
12
-
-
79951646720
-
Phase II multiple-dose study of the safety and toler-ability of niacin 30 mg and 60 mg combined with oxycodone HCl 5 mg versus oxycodone HCl 5 mg alone in healthy adult volunteers
-
Poster presented at 20-25 June Reno/Sparks, NV, USA
-
Freeland DV, Spivey R. Phase II multiple-dose study of the safety and toler-ability of niacin 30 mg and 60 mg combined with oxycodone HCl 5 mg versus oxycodone HCl 5 mg alone in healthy adult volunteers. Poster presented at: 71st Annual Meeting of the College on Problems of Drug Dependence, 20-25 June 2009, Reno/Sparks, NV, USA
-
(2009)
71st Annual Meeting of the College on Problems of Drug Dependence
-
-
Freeland, D.V.1
Spivey, R.2
-
13
-
-
79951666269
-
Phase II study to evaluate the dose response for flushing, safety, and tolerability of escalating doses of niacin in fasted and fed healthy adult volunteers
-
Poster presented at 20-25 June Reno/Sparks, NV, USA
-
Wood R, Spivey R. Phase II study to evaluate the dose response for flushing, safety, and tolerability of escalating doses of niacin in fasted and fed healthy adult volunteers. Poster presented at: 71st Annual Meeting of the College on Problems of Drug Dependence, 20-25 June 2009, Reno/Sparks, NV, USA
-
(2009)
71st Annual Meeting of the College on Problems of Drug Dependence
-
-
Wood, R.1
Spivey, R.2
-
14
-
-
79951614067
-
A phase II single-center randomized double-blind assessment of the subjective effects of Acurox® (oxycodone HCl/niacin) tablets in volunteers with a history of opioid abuse
-
Poster presented 30 April - 3 May New Orleans, LA, USA. Poster 34
-
Jasinski DR. A phase II, single-center, randomized, double-blind assessment of the subjective effects of Acurox® (oxycodone HCl/niacin) tablets in volunteers with a history of opioid abuse. Poster presented at: 40th Annual Medical-Scientific Conference of the American Society of Addiction, 30 April - 3 May, 2009, New Orleans, LA, USA. Poster 34
-
(2009)
40th Annual Medical-Scientific Conference of the American Society of Addiction
-
-
Jasinski, D.R.1
-
15
-
-
67649378979
-
A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain
-
Daniels SE, Upmalis D, Okamoto A, et al. A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain. Curr Med Res Opin 2009; 25:765-76
-
(2009)
Curr Med Res Opin
, vol.25
, pp. 765-76
-
-
Daniels, S.E.1
Upmalis, D.2
Okamoto, A.3
-
16
-
-
0025966840
-
Soft-tissue bunionectomy in podiatric surgery
-
Ford LB. Soft-tissue bunionectomy in podiatric surgery. Clin Podiatr Med Surg 1991;8:63-70
-
(1991)
Clin Podiatr Med Surg
, vol.8
, pp. 63-70
-
-
Ford, L.B.1
-
18
-
-
0037406025
-
Clinically important changes in acute pain outcome measures: A validation study
-
DOI 10.1016/S0885-3924(03)00162-3
-
Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: a validation study. J Pain Symptom Manag 2003; 25:406-11 (Pubitemid 36506668)
-
(2003)
Journal of Pain and Symptom Management
, vol.25
, Issue.5
, pp. 406-411
-
-
Farrar, J.T.1
Berlin, J.A.2
Strom, B.L.3
-
19
-
-
67649435616
-
A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain
-
Daniels S, Casson E, Stegmann JU, et al. A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain. Curr Med Res Opin 2009; 25:1551-61
-
(2009)
Curr Med Res Opin
, vol.25
, pp. 1551-61
-
-
Daniels, S.1
Casson, E.2
Stegmann, J.U.3
-
20
-
-
7644241637
-
A randomized controlled study comparing rofecoxib, diclofenac sodium, and placebo in post-bunionectomy pain
-
DOI 10.1185/030079904X3069
-
Desjardins PJ, Black PM, Daniels S, et al. A randomized controlled study comparing rofecoxib, diclofenac sodium, and placebo in post-bunionectomy pain. Curr Med Res Opin 2004;20:1523-37 (Pubitemid 39457541)
-
(2004)
Current Medical Research and Opinion
, vol.20
, Issue.10
, pp. 1523-1537
-
-
Desjardins, P.J.1
Black, P.M.2
Daniels, S.3
Bird, S.R.4
Fitzgerald, B.J.5
Petruschke, R.A.6
Tershakovec, A.7
Chang, D.J.8
-
21
-
-
79951643956
-
-
North Chicago IL: Abbott Laboratories
-
Niaspan [package insert]. North Chicago IL: Abbott Laboratories, 2010
-
(2010)
Niaspan [Package Insert]
-
-
-
23
-
-
62149148657
-
The efficacy and tolerability of multiple-dose tapentadol immediate release for the relief of acute pain following orthopedic (bunionectomy) surgery
-
Stegmann J-U, Weber H, Steup A, et al. The efficacy and tolerability of multiple-dose tapentadol immediate release for the relief of acute pain following orthopedic (bunionectomy) surgery. Curr Med Res Opin 2008;24: 3185-96
-
(2008)
Curr Med Res Opin
, vol.24
, pp. 3185-96
-
-
Stegmann, J.-U.1
Weber, H.2
Steup, A.3
-
25
-
-
1842786077
-
Lessons learned from a multiple-dose post-operative analgesic trial
-
DOI 10.1016/j.pain.2004.01.015, PII S0304395904000375
-
Mendoza TR, Chen C, Brugger A, et al. Lessons learned from a multiple-dose post-operative analgesic trial. Pain 2004;109:103-9 (Pubitemid 38479775)
-
(2004)
Pain
, vol.109
, Issue.1-2
, pp. 103-109
-
-
Mendoza, T.R.1
Chen, C.2
Brugger, A.3
Hubbard, R.4
Snabes, M.5
Palmer, S.N.6
Zhang, Q.7
Cleeland, C.S.8
-
26
-
-
79951648430
-
-
Palatine, IL: Acura Pharmaceuticals, Inc., April 22 Available Last accessed 4 Nov 2010
-
Acurox (oxycodone HCl, USP and niacin, USP) Tablets: NDA 22-451. Briefing information for a joint meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee. Palatine, IL: Acura Pharmaceuticals, Inc., April 22, 2010. Available at: http://www.fda.gov/downloads/AdvisoryCommittees/Committees MeetingMaterials/ Drugs/AnestheticAndLifeSupportDrugsAdvisoryCommittee/ UCM209143.pdf [Last accessed 4 Nov 2010]
-
(2010)
Acurox (Oxycodone HCl, USP and Niacin, USP) Tablets: NDA 22-451. Briefing Information for A Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee
-
-
|